Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02391116
Title Phase II Copanlisib in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Bayer
Indications
Therapies
Age Groups: adult
Covered Countries ITA | GBR | FRA | DEU | CAN | BEL | AUS

Facility Status City State Zip Country Details
Kingswood New South Wales 2747 Australia Details
Ballarat Victoria 3350 Australia Details
Prahran Victoria 3181 Australia Details
Box Hill 3128 Australia Details
Wilrijk Antwerpen 2610 Belgium Details
Bruxelles - Brussel 1200 Belgium Details
Edegem 2650 Belgium Details
Gent 9000 Belgium Details
Leuven 3000 Belgium Details
St. John's Newfoundland and Labrador A1B 3V6 Canada Details
Brampton Ontario L6R 3J7 Canada Details
Montreal Quebec H1T 2M4 Canada Details
Montreal Quebec H3T 1E2 Canada Details
Sherbrooke Quebec J1H 5N4 Canada Details
Aarhus C 8000 Denmark Details
Odense C 5000 Denmark Details
Caen Cedex 14033 France Details
Creteil 94010 France Details
Lille 59037 France Details
PARIS cedex 75475 France Details
Pierre Benite 69310 France Details
POITIERS cedex 86021 France Details
Münster Nordrhein-Westfalen 48149 Germany Details
Leipzig Sachsen Germany Details
Berlin 10967 Germany Details
Milano Lombardia 20089 Italy Details
Seoul 05505 Korea, Republic of Details
Seoul 110-744 Korea, Republic of Details
Singapore 169610 Singapore Details
Truro Cornwall TR1 3LJ United Kingdom Details
Southampton Hampshire SO16 6YD United Kingdom Details
London NW1 2PG United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field